Talks to strengthen Sino-Russia pharmaceutical industry cooperation

6 July 2015

A Russian pharmaceutical delegation, composed of over 50 representatives from more than 20 companies and led by Sergey Tsyb, the deputy director of the Ministry of Industrial and Trade of Russia, attended the recent 2015 CPhI China for the first time. During the exhibition, delegates also conducted a dialogue about pharmaceutical industry.

Mr Tsyb had a discussion with Ms Meng Dongping, the vice president of the China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE) – which co-hosted the exhibitoin, on how to strengthen cooperation on the pharmaceutical industry of the two sides. Mr Tsyb thought highly of the rapid development of China’s pharmaceutical industry, and gave his explanation about how Russia would advance the progress of its local pharmaceutical industry.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

More ones to watch >